Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy

The αvβ6 integrin receptor has been shown to be overexpressed on many types of cancer cells, resulting in a more pro-invasive and aggressive phenotype, this makes it an attractive target for selective drug delivery. In tumours that over-express the αvβ6 receptor, cellular uptake of liposomes can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodgins, Naomi O., Al-Jamal, Wafa' T., Wang, Julie T.-W., Klippstein, Rebecca, Costa, Pedro M., Sosabowski, Jane K., Marshall, John F., Maher, John, Al-Jamal, Khuloud T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488751/
https://www.ncbi.nlm.nih.gov/pubmed/28432037
http://dx.doi.org/10.1016/j.jconrel.2017.04.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488751/
https://www.ncbi.nlm.nih.gov/pubmed/28432037
http://dx.doi.org/10.1016/j.jconrel.2017.04.025

Ejemplares similares